Nabis Holdings Announces Resignation of Board Member
06 September 2019 - 10:32PM
Nabis Holdings Inc. (CSE:NAB) (OTC: NABIF) (FRA:
A2PL) (“Nabis™” or the “Company”), a leading Canadian investment
company with specialty investments in assets across multiple
divisions of the cannabis sector, today announced that Kevin Ma has
resigned from the Company’s Board of Directors, effective September
6, 2019, in order to focus on other business obligations. Mr. Ma
will continue to perform consulting services for Nabis.
Shay Shnet, CEO & Director of Nabis,
commented, “Kevin has played an integral part in building the
Company as it exists today and we sincerely thank him for his
dedicated work and support. We look forward to receiving his
continued wisdom and guidance in a consulting capacity going
forward.”
The Company has restructured its board this year
with the election of two independent members and the appointment of
Mr. Emmanuel Paul, an industry veteran with considerable experience
in the cannabis industry. With Mr. Paul's installation last month,
Nabis' board has 4 out of 6 independent board members.
About Nabis Holdings Inc.Nabis
Holdings is a Canadian investment issuer that invests in high
quality cash flowing assets across multiple industries, including
real property, securities, cryptocurrency, and all aspects of the
U.S. and international cannabis sector. Led by two of the
co-founders of MPX Bioceutical, one of the largest takeovers in the
U.S. Cannabis space to date, the company has a proven track record
in emerging markets to create significant shareholder value. The
Company is focused on investing across the entire vertically
integrated aspects of the space with a focus on revenue generation,
EBITDA and growth.
For more information, please visit
https://www.nabisholdings.com/.
Forward-Looking StatementsAll
statements, other than statements of historical fact, included
herein are forward-looking statements that involve various risks
and uncertainties. There can be no assurance that such statements
will prove to be accurate and actual results and future events
could differ materially from those anticipated in such statements.
The risks are without limitations: that the acquisitions will be
completed by the Company or completed upon the terms disclosed; the
price for cannabis and related products will remain consistent and
the consumer demand remains strong; availability of financing to
the Company to develop the retail locations; retention of key
employees and management; changes in State and/or municipal
regulations of retail operations and changes in government
regulations generally. Important factors that could cause actual
results to differ materially from the Company’s expectations are
disclosed in the Company’s documents filed from time to time with
the Canadian Securities Exchange, the British Columbia Securities
Commission, the Ontario Securities Commission and the Alberta
Securities Commission.
The CSE does not accept responsibility for the adequacy
or accuracy of this release.
For inquiries, please contact:
Investor Contact:Allison SossKCSA Strategic
Communications PH: 212-896-1267Nabis@kcsa.com
Company Contact:Shay Shnet, CEO
and DirectorPH: 905-581-5521 x107info@nabisholdings.com
Nabis (CSE:NAB)
Historical Stock Chart
From Jun 2024 to Jul 2024
Nabis (CSE:NAB)
Historical Stock Chart
From Jul 2023 to Jul 2024